trending Market Intelligence /marketintelligence/en/news-insights/trending/p6DMBuBi7mXx9W8k9BCHOA2 content esgSubNav
In This List

US FDA clears Immunicum's application for renal cell cancer drug

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery


US FDA clears Immunicum's application for renal cell cancer drug

Immunicum AB (publ) said the U.S. FDA cleared the company's investigational new drug application for INTUVAX for the treatment of metastatic renal cell cancer.

The clearance enables the company to expand its ongoing phase 2 study in the U.S.